Effect of macrophage migration inhibitory factor (MIF) in human placental explants infected with toxoplasma gondii depends on gestational age

American Journal of Pathology

Volumn 178, Issue 6, 2011, Pages 2792-2801

  De Oliveira Gomes, Angelica ^a   De Oliveira Silva, Deise Aparecida ^a   Silva, Neide Maria ^a   De Freitas Barbosa, Bellisa ^a   Silva Franco, Priscila ^a   Angeloni, Mariana Bodini ^a   Fermino, Marise Lopes ^b   Roque Barreira, Maria Cristina ^b   Bechi, Nicoletta ^c   Paulesu, Luana Ricci ^c   Dos Santos, Maria Célia ^a   Mineo, José Roberto ^a   Ferro, Eloisa Amália Vieira ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; MACROPHAGE MIGRATION INHIBITION FACTOR; MACROPHAGE MIGRATION INHIBITION FACTOR RECEPTOR; PROTOZOAL DNA; RECEPTOR; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXPLANT; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION CONTROL; INFECTION SENSITIVITY; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; SUPERNATANT; TACHYZOITE; THIRD TRIMESTER PREGNANCY; TOXOPLASMA GONDII; TOXOPLASMOSIS; UPREGULATION;

EID: 79959401486     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.02.005     Document Type: Article

References (55)

1. Tenter AM, Heckeroth AR, Weiss LM: Toxoplasma gondii: from animals to humans. Int J Parasitol 2000, 30:1217-1258
2. Lang C, Gross U, Lüder CG: Subversion of innate and adaptive immune responses by Toxoplasma gondii. Parasitol Res 2007, 100: 191-203 (Pubitemid 44900251)
3. Ambroise-Thomas P, Pelloux H: Toxoplasmosis: congenital and in immunocompromised patients; a parallel. Parasitol Today 1993, 9:61-63 (Pubitemid 23038651)
4. Ferreira MS, Borges AS: Some aspects of protozoan infections in immunocompromised patients: a review. Mem Inst Oswaldo Cruz 2002, 97:443-457 (Pubitemid 135746784)
5. Rorman E, Zamir CS, Rilkis I, Bem-David H: Congenital toxoplasmosis: prenatal aspects of Toxoplasma gondii infection. Reprod Toxicol 2006, 21:458-472
6. Ajzenberg D, Cogné N, Paris L, Bessières MH, Thulliez P, Filisetti D, Pelloux H, Marty P, Dardé ML: Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis 2002, 186:684-689 (Pubitemid 34925541)
7. Maubon D, Ajzenberg D, Brenier-Pinchart MP, Dardé ML, Pelloux H: What are the respective host and parasite contributions to toxoplasmosis? Trends Parasitol 2008, 24:299-303
8. Rouas-Freiss N, Gonçalves RM, Menier C, Dausset J, Carosella ED: Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997, 94:11520-11525 (Pubitemid 27451031)
9. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998, 281:1191-1193 (Pubitemid 28406294)
10. Aluvihare VR, Kallikourdis M, Betz AG: Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004, 5:266-271 (Pubitemid 38332123)
11. Krishnan L, Guilbert LJ, Russell AS, Wegmann TG, Mosmann TR, Belosevic M: Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN response and increased production of Th2 cytokines. J Immunol 1996, 156:644-652 (Pubitemid 26028923)
12. Piccinni MP, Giudizi MG, Biagiotti R, Beloni L, Giannarini L, Sampognaro S, Parronchi P, Manetti R, Annunziato F, Livi C: Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995, 155:128-133
13. Miyaura H, Iwata M: Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol 2002, 168:1087-1094 (Pubitemid 34094472)
14. Luft BJ, Remington JS: Effect of pregnancy on resistance to Listeria monocytogenes and Toxoplasma gondii infection in mice. Infect Immun 1982, 38:1164-1171 (Pubitemid 13206268)
15. Ietta F, Todros T, Ticconi C, Piccoli E, Zicari A, Piccione E, Paulesu L: Macrophage migration inhibitory factor in human pregnancy and labor. Am J Reprod Immunol 2002, 48:404-409 (Pubitemid 35469292)
16. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R: MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995, 377:68-71
17. David J: Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 1966, 56:72-77
18. Bloom BR, Bennett B: Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966, 153:80-82
19. Amano T, Nishihira J, Miki I: Blockade of macrophage migration inhibitory factor (MIF) prevents the antigen-induced response in a murine model of allergic airway inflammation. Inflamm Res 2007, 56:24-31 (Pubitemid 46356224)
20. Baumann R, Casaulta C, Simon D, Conus S, Yousefi S, Simon HU: Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway. FASEB J 2003, 17:2221-2230 (Pubitemid 37509578)
21. Martiney JA, Sherry B, Metz CN, Espinoza M, Ferrer AS, Calandra T, Broxmeyer HE, Bucala R: Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudiinfected erythrocytes: possible role in the pathogenesis of malaria. Infect Immun 2000, 68:2259-2267 (Pubitemid 30164863)
22. Chaisavaneeyakorn S, Lucchi N, Abramowsky C, Othoro C, Chaiyaroj SC, Shi YP, Nahlen BL, Peterson DS, Moore JM, Udhayakumar V: Immunohistological characterization of macrophage migration inhibitory factor expression in Plasmodium falciparum-infected placentas. Infect Immun 2005, 73:3287-3293 (Pubitemid 40745868)
23. Jüttner S, Bernhagen J, Metz CN, Röllinghoff M, Bucala R, Gessner A: Macrophage migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. J Immunol 1998, 161:2383-2390 (Pubitemid 28397052)
24. Reyes JL, Terrazas LI, Espinoza B, Cruz-Robles D, Soto V, Rivera- Montoya I, Gómez-García L, Snider H, Satoskar AR, Rodríguez-Sosa M: Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection. Infect Immun 2006, 74:3170-3179 (Pubitemid 43794505)
25. Ferro EA, Mineo JR, Ietta F, Bechi N, Romagnoli R, Silva DA, Sorda G, Bevilacqua E, Paulesu LR: Macrophage migration inhibitory factor is up-regulated in human first trimester placenta stimulated by soluble antigen of Toxoplasma gondii, resulting in increased monocyte adhesion on villus explants. Am J Pathol 2008, 172:50-58 (Pubitemid 351186367)
26. Flores M, Saavedra R, Bautista R, Viedma R, Tenorio EP, Leng L, Sánchez Y, Juárez I, Satoskar AA, Shenoy AS, Terrazas LI, Bucala R, Barbi J, Satoskar AR, Rodriguez-Sosa M: Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii. FASEB J 2008, 22:3661-3671
27. Terrazas CA, Juarez I, Terrazas LI, Saavedra R, Calleja EA, Rodriguez- Sosa M: Toxoplasma gondii: impaired maturation and pro-inflammatory response of dendritic cells in MIF-deficient mice favors susceptibility to infection. Exp Parasitol 2010, 126:348-358
28. Rodríguez-Sosa M, Rosas LE, David JR, Bojalil R, Satoskar AR, Terrazas LI: Macrophage migration inhibitory factor plays a critical role in mediating protection against the helminth parasite Taenia crassiceps. Infect Immun 2003, 71:1247-1254 (Pubitemid 36254308)
29. Koebernick H, Grode L, David JR, Rohde W, Rolph MS, Mittrücker HW, Kaufmann SH: Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc Natl Acad Sci USA 2002, 99:13681-13686 (Pubitemid 35215441)
30. Caniggia I, Taylor CV, Ritchie JW, Lye SJ, Letarte M: Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villus explants. Endocrinol 1997, 138:4977-4988 (Pubitemid 27460938)
31. Mineo JR, Camargo ME, Ferreira AW: Enzyme-linked immunosorbent assay for antibodies to Toxoplasma gondii polysaccharides in human toxoplasmosis. Infect Immun 1980, 27:283-287 (Pubitemid 10144912)
32. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR: Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982, 126:131-138 (Pubitemid 13203451)
33. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254
34. Watson ML: Staining of tissue sections for electron microscopy with heavy metals. J Biophys Biochem Cytol 1958, 4:475-478
35. Reynolds ES: The use of lead citrate at high pH as on electron opaque stain in electron microscopy. J Cell Biol 1963, 17:208-212
36. Bieche I, Parfait B, Le Doussal V, Olivi M, Rio MC, Lidereau R, Vidaud M: Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. Cancer Res 2001, 61:1652-1658 (Pubitemid 34292601)
37. Boyd JD, Hamilton WJ: The Human Placenta. Cambridge, England, W. Heffer & Sons Ltd., 1970, pp 1-172
38. Ranella A, Vassiliadis S, Mastora C, Valentina M, Dionyssopoulou E, Athanassakis I: Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells. Hum Immunol 2005, 66:43-55 (Pubitemid 40037710)
39. Flaster H, Bernhagen J, Calandra T, Bucala R: The macrophage migratory inhibitory factor- glucocorticoid dyad: regulation of inflammation and immunity. Mol Endrocrinol 2007, 21:1267-1280 (Pubitemid 46984737)
40. Banerjee S, Smallwood A, Moorhead J, Chambers AE, Papageorghiou A, Campbell S, Nicolaides K: Placental expression of interferon-gamma (IFN-gamma) and its receptor IFN-gamma R2 fail to switch from early hypoxic to late normotensive development in preeclampsia. J Clin Endocrinol Metab 2005, 90:944-952 (Pubitemid 40279220)
41. Létourneau S, van Leeuwen EM, Krieg C, Martin C, Pantaleo G, Sprent J, Surh CD, Boyman O: IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25. Proc Natl Acad Sci USA 2010, 107:2171-2176
42. Jones AT, Ziltener HJ: Enhancement of the biologic effects of interleukin- 3 in vivo by anti-interleukin-3 antibodies. Blood 1993, 82:1133-1141 (Pubitemid 23253986)
43. Martens E, Dillen C, Put W, Heremans H, van Damme J, Billiau A: Increased circulating interleukin-6 (IL-6) activity in endotoxin-challenged mice pretreated with anti-IL-6 antibody is due to IL-6 accumulated in antigen-antibody complexes. Eur J Immunol 1993, 23: 2026-2029 (Pubitemid 23236805)
44. Espejo C, Penkowa M, Sáez-Torres I, Xaus J, Celada A, Montalban X, Martínez-Cáceres EM: Treatment with anti-interferon-gamma monoclonal antibodies modifies experimental autoimmune encephalomyelitis in interferon-gamma receptor knockout mice. Exp Neurol 2001, 172:460-468 (Pubitemid 34075095)
45. Lee VW, Coan MH, Galloway CJ: Conjugated anti-TNF antibodies enhance the binding and degradation of TNF. Biotechnol Ther 1992, 3:51-62
46. Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C, David JR: Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 1999, 189:341-346 (Pubitemid 29063255)
47. Shi X, Leng L, Wang T, Wang W, Du X, Li J, McDonald C, Chen Z, Murphy JW, Lolis E, Noble P, Knudson W, Bucala R: CD44 is the signaling component of the macrophage migration inhibitory factor- CD74 receptor complex. Immunity 2006, 25:595-606 (Pubitemid 44529040)
48. Mitchell RA, Metz CN, Peng T, Bucala R: Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF): regulatory role in cell proliferation and glucocorticoid action. J Biol Chem 1999, 274: 18100-18106
49. 2+ and protein kinase C regulate innate recognition of Toxoplasma gondii. J Cell Sci 2006, 119:4565-4573 (Pubitemid 44830655)
50. Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J: Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000, 408:211-216
51. Calandra T, Roger T: Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003, 3:791-800 (Pubitemid 37328657)
52. Miller RK, Genbacev O, Turner MA, Aplin JD, Caniggia I, Huppertz B: Human placental explants in culture: approaches and assessments. Placenta 2005, 26:439-448 (Pubitemid 40796572)
53. Desmonts G, Couvreur J: Congenital toxoplasmosis: a prospective study of 378 pregnancies. N Engl J Med 1974, 290:1110-1116
54. Loke YW: Transmission of parasites across the placenta. Adv Parasitol 1982, 21:155-228
55. Barragan A, Sibley LD: Transepithelial migration of Toxoplasma gondii is linked to parasite motility and virulence. J Exp Med 2002, 195:1625-1633 (Pubitemid 34666075)